Note dell’episodio
This is the fourth of seven episodes covering ovarian cancer. In this episode, we discuss the management of recurrent, platinum-resistant epithelial ovarian cancer. Join us to explore the prognosis of PROC, recommendations for systemic chemotherapy, the role of bevacizumab, the updates to FDA approval for PARPi use, and options for targeted therapies, including recent updates.
Join us for bi-weekly episodes on gynecologic cancer or check out our episode archive and show notes at readysetgyo.com. Follow us on Instagram @ReadySetGYOPod. Find us on Twitter and support us on Patreon…
Sito web: readysetgyopod.podbean.com

